Hematologic Cancer

HEMATOLOGIC CANCER ADVISOR

HEADLINES
TREATMENT REGIMENS
DRUG INFORMATION

FEATURED CONTENT

Biosimilars in Cancer Care: Insights From 2020 and Expectations for 2021

Sean McGowan, senior director of Biosimilars at AmerisourceBergen, and Brian Ansay, senior vice president of Sales and Corporate Services at ION Solutions, review 2020 biosimilar trends in oncology and forecast what is ahead in 2021.
Sodium Bicarbonate Associated With Enhanced GVL Effect in AML Following Allo-HSCT

Investigators assessed sodium bicarbonate’s viability as a pharmacologic strategy in mouse models and humans with acute myeloid leukemia.
Study Shows Convalescent Plasma Is Beneficial for COVID-19 Patients With Hematological Malignancies

Despite mixed evidence for the general population, cumulative research reveals dramatic improvement with convalescent plasma for blood cancer patients, especially when given early.
Current State and Future Directions for Treating NPM1-Mutated Acute Myeloid Leukemia

Investigators addressed challenges associated with the biology, diagnosis, and current state of treatment for patients with NPM1-mutated AML.
Community Health Status Affects Survival Post HCT

Investigators calculated patient community risk scores and center community risk scores to study the impact of community factors on patient outcomes following hematopoietic stem cell transplant.

HEMATOLOGIC CANCER NEWS

Narsoplimab Under Review for Stem Cell Transplant-Associated Thrombotic Microangiopathy

January 20, 2021

Male doctor explaining results to middlea-ged female patient in hallway

Carriers of CALR Mutations at Decreased Risk for Thrombotic Events Among Patients With Essential Thrombocythemia

January 20, 2021

First Treatment for Newly Diagnosed Light Chain Amyloidosis Approved

January 19, 2021

FDA_drug approval

Xalkori Approved for Anaplastic Large Cell Lymphoma in Children and Young Adults

January 19, 2021

Do proton ?radiotherapy collimators pose neutron radiation risks?

Total Body Irradiation vs Chemotherapy Conditioning for Pediatric Acute Lymphoblastic Leukemia

January 14, 2021

Next post in Hematologic Cancers

First Treatment for Newly Diagnosed Light Chain Amyloidosis Approved